4.2 Review

Early Intervention in Psychosis Obvious, Effective, Overdue

期刊

JOURNAL OF NERVOUS AND MENTAL DISEASE
卷 203, 期 5, 页码 310-318

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/NMD.0000000000000284

关键词

Early intervention; psychosis; prevention; service reform

资金

  1. Colonial Foundation
  2. National Health and Medical Research Council of Australia
  3. NARSAD
  4. Stanley Foundation
  5. Australian government
  6. Victorian government
  7. Janssen-Cilag
  8. Astra Zeneca
  9. Bristol-Meyer-Squibb
  10. Eli Lilly
  11. Pfizer

向作者/读者索取更多资源

Early intervention for potentially serious disorder is a fundamental feature of healthcare across the spectrum of physical illness. It has been a major factor in the reductions in morbidity and mortality that have been achieved in some of the non-communicable diseases, notably cancer and cardiovascular disease. Over the past two decades, an international collaborative effort has been mounted to build the evidence and the capacity for early intervention in the psychotic disorders, notably schizophrenia, where for so long deep pessimism had reigned. The origins and rapid development of early intervention in psychosis are described from a personal and Australian perspective. This uniquely evidence-informed, evidence-building and cost-effective reform provides a blueprint and launch pad to radically change the wider landscape of mental health care and dissolve many of the barriers that have constrained progress for so long.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据